ShanghaiTech University Knowledge Management System
Hormone- and antibody-mediated activation of the thyrotropin receptor | |
2022-08-01 | |
发表期刊 | NATURE (IF:50.5[JCR-2023],54.4[5-Year]) |
ISSN | 0028-0836 |
EISSN | 1476-4687 |
发表状态 | 已发表 |
DOI | 10.1038/s41586-022-05173-3 |
摘要 | Thyroid-stimulating hormone (TSH), through activation of its G-protein-coupled thyrotropin receptor (TSHR), controls the synthesis of thyroid hormone-an essential metabolic hormone(1-3). Aberrant signalling of TSHR by autoantibodies causes Graves' disease (hyperthyroidism) and hypothyroidism, both of which affect millions of patients worldwide(4). Here we report the active structures of TSHR with TSH and the activating autoantibody M22(5), both bound to the allosteric agonist ML-109(6), as well as an inactivated TSHR structure with the inhibitory antibody K1-70(7). Both TSH and M22 push the extracellular domain (ECD) of TSHR into an upright active conformation. By contrast, K1-70 blocks TSH binding and cannot push the ECD into the upright conformation. Comparisons of the active and inactivated structures of TSHR with those of the luteinizing hormone/choriogonadotropin receptor (LHCGR) reveal a universal activation mechanism of glycoprotein hormone receptors, in which a conserved ten-residue fragment (P10) from the hinge C-terminal loop mediates ECD interactions with the TSHR transmembrane domain(8). One notable feature is that there are more than 15 cholesterols surrounding TSHR, supporting its preferential location in lipid rafts(9). These structures also highlight a similar ECD-push mechanism for TSH and autoantibody M22 to activate TSHR, therefore providing the molecular basis for Graves' disease. |
URL | 查看原文 |
收录类别 | SCI ; SCIE |
语种 | 英语 |
资助项目 | Ministry of Science and Technology (China)[2018YFA0507002] ; CAS Strategic Priority Research Program[XDB37030103] ; National Natural Science Foundation of China["32130022","32171187","82121005"] ; CAMS Innovation Fund for Medical Sciences["2021-CAMS-JZ004","2021-I2M-1-003"] ; Tsinghua University-Peking University Center for Life Sciences[045-61020100121] ; National Science & Technology Major Project 'Key New Drug Creation and Manufacturing Program' of China[2018ZX09711002] ; Science and Technology Commission of Shanghai Municipal[20431900100] ; Jack Ma Foundation[2020-CMKYGG-05] |
WOS研究方向 | Science & Technology - Other Topics |
WOS类目 | Multidisciplinary Sciences |
WOS记录号 | WOS:000852585100002 |
出版者 | NATURE PORTFOLIO |
引用统计 | 正在获取...
|
文献类型 | 期刊论文 |
条目标识符 | https://kms.shanghaitech.edu.cn/handle/2MSLDSTB/229828 |
专题 | 免疫化学研究所_特聘教授组_蒋华良组 生命科学与技术学院 生命科学与技术学院_特聘教授组_徐华强组 |
通讯作者 | Zhang, Shuyang; Jiang, Yi; Xu, H. Eric |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai, Peoples R China 2.Univ Chinese Acad Sci, Beijing, Peoples R China 3.Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Cardiol, Beijing, Peoples R China 4.Peking Union Med Coll & Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Res Ctr, Beijing, Peoples R China 5.Tsinghua Univ, Sch Med, Beijing, Peoples R China 6.Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China 7.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China 8.Chinese Acad Sci, Ctr Immunol Dis, Shanghai Inst Mat Med, Shanghai, Peoples R China 9.ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China 10.Lingang Lab, Shanghai, Peoples R China 11.MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA |
通讯作者单位 | 生命科学与技术学院 |
推荐引用方式 GB/T 7714 | Duan, Jia,Xu, Peiyu,Luan, Xiaodong,et al. Hormone- and antibody-mediated activation of the thyrotropin receptor[J]. NATURE,2022. |
APA | Duan, Jia.,Xu, Peiyu.,Luan, Xiaodong.,Ji, Yujie.,He, Xinheng.,...&Xu, H. Eric.(2022).Hormone- and antibody-mediated activation of the thyrotropin receptor.NATURE. |
MLA | Duan, Jia,et al."Hormone- and antibody-mediated activation of the thyrotropin receptor".NATURE (2022). |
条目包含的文件 | ||||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 |
修改评论
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。